Aurora Cannabis Inc. produces and distributes medical cannabis products around the world. It is vertically integrated and horizontally diversified in various segments of the cannabis value chain, including facility engineering and design, cannabis cultivation, genetic research, production, derivatives, high value-added product development, domestic cultivation, wholesale and retail distribution.
Aurora looks at an improvement in EBITDA for the third quarter after reductions to its number of employees a few months ago. Cost cutting. Reduced its operating expenses by 6.6% quarterly
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.